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Structural Basis for Relief of Autoinhibition
of the Dbl Homology Domain of Proto-Oncogene Vav
by Tyrosine Phosphorylation
Each member is capable of promoting distinct actin-
based cytoskeletal structures required for cell adhesion
and motility in morphogenic, chemotactic, and profilera-
tive responses (Hall, 1998). These GTPases also control
cell growth and apoptosis through activation of the ex-
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conserved region termed the Dbl homology (DH) domain
that is responsible for catalyzing the nucleotide ex-
change (Cerione and Zheng, 1996). In contrast to the
Summary Ras-GEF Sos, which appears to be activated largely
through receptor-mediated translocation to cell mem-
Rho-family GTPases transduce signals from receptors branes (where the GTPase resides [Downward, 1996])
leading to changes in cell shape and motility, mitogen- the mechanisms whereby upstream signals are relayed
esis, and development. Proteins containing the Dbl to the Dbl GEFs are poorly understood. While activation
homology (DH) domain are responsible for activating of these proteins also involves cellular targeting, other
Rho GTPases by catalyzing the exchange of GDP for regulatory mechanisms are clearly important as well
GTP. Receptor-initiated stimulation of Dbl protein Vav (Cerione and Zheng, 1996). The significance of DH do-
exchange activity involves tyrosine phosphorylation. main regulation is evidenced by involvement in dis-
We show through structure determination that the eases. Indeed, many members of the Dbl family GEFs
mVav1 DH domain is autoinhibited by an N-terminal were initially identified based on their oncogenic poten-
extension, which lies in the GTPase interaction site. tial (Cerione and Zheng, 1996), or have been directly
This extension contains the Tyr174 Src-family kinase linked to developmental disorders (Pasteris et al., 1994)
recognition site, and phosphorylation or truncation of and tumor metastasis (Michiels et al., 1995).
this peptide results in stimulation of GEF activity. NMR One of the best characterized Rho-GEF proteins is
spectroscopy data show that the N-terminal peptide the proto-oncogene product, Vav. This protein is essen-
is released from the DH domain and becomes unstruc- tial for cytoskeletal, proliferative, and apoptotic path-
tured upon phosphorylation. Thus, tyrosine phosphor- ways in lymphoid cell development and signaling re-
ylation relieves autoinhibition by exposing the GTPase sponses. B and T lymphocytes derived from Vav 2/2
interaction surface of the DH domain, which is obliga- mice show defective antigen receptor induced prolifera-
tory for Vav activation. tion (Fischer et al., 1995; Tarakhovsky et al., 1995; Zhang
et al., 1995) and F-actin polymerization (Fischer et al.,
1998; Holsinger et al., 1998). Stimulation of Vav resultsIntroduction
in Rac-mediated formation of lamellipodia and activa-
tion of JNK in vivo (Crespo et al., 1996), and Vav GEF
Members of the Ras superfamily of GTPases regulate a
activity is specific for Rac in vitro (Crespo et al., 1997).
diverse array of intracellular signaling pathways required
Vav and its homologs, Vav2 and Vav3, are composed
for normal and transformed cell growth. These proteins of an N-terminal calponin homology (CH) domain (resi-
act as molecular switches by cycling between active dues 1–116) followed by an acidic region (Ac) (132–176),
GTP-bound and inactive GDP-bound states. Two classes the DH (185–375) and PH (pleckstrin homology) (398–
of proteins accelerate their low intrinsic rate of nucleo- 508) domains common to all Rho GEFs, a zinc finger
tide cycling: GTPase activating proteins (GAPs) catalyze (ZF) (516–565) domain, a short proline-rich region (PR)
the hydrolysis of the terminal phosphate group of (607–610), and an SH3-SH2-SH3 (612–844) module at
the bound nucleotide to render the GTPases inactive, the C terminus (Bustelo, 1996). Interactions between
whereas guanine nucleotide exchange factors (GEFs) pro- different regions of Vav are involved in regulating the
mote acquisition of the active state by accelerating the GEF activity of the DH domain. Vav becomes rapidly
exchange of GDP for GTP. Structural differences associ- phosphorylated in response to antigen stimulation of
ated with the two nucleotide states allow GTPases to the B- and T-cell receptors (Bustelo and Barbacid, 1992;
selectively target downstream effectors when activated Bustelo et al., 1992; Margolis et al., 1995) through the
(Bourne et al., 1991; Boguski and McCormick, 1993). action of Syk and Src-family tyrosine kinases (Deckert
The Rho-family GTPases, Rho, Rac, and Cdc42, are et al., 1996; Han et al., 1997). This phosphorylation event
primarily known as regulators of the actin cytoskeleton. results in the stimulation of nucleotide exchange activity
(Crespo et al., 1997). Although there is evidence of addi-
tional phospho-tyrosine residues regulating GEF activ-kTo whom correspondence should be addressed (e-mail: rosen@
mrnmr1.mskcc.org). ity, the best characterized are three conserved sites in
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the Ac region. Of these, Tyr174 is the most extensively molecule, the Vav DH domain is both active and capable
of exerting GTPase selectivity, and Tyr174 functions asstudied and has been shown to be a substrate for Syk
and the Src-family tyrosine kinase, Lck (Brunati et al., the main regulatory site of GEF activity.
1995; Han et al., 1997). Phosphorylation of this residue
enhances GEF activity in vitro (Han et al., 1997) and Structure Determination
truncation of the N-terminal 186 residues (D1–186) leads To better understand the mechanism of inhibition by
to phosphorylation independent activation of Vav2 GEF the N-terminal extension, we determined the solution
function (Schuebel et al., 1998). Compared to Vav mole- structure of Vav170–375 by NMR spectroscopy. Struc-
cules containing Tyr174, Vav (D1–186) is up to 100-fold ture determination of this 24 kDa fragment required utili-
more potent in focus formation assays when transfected zation of recently developed isotopic labeling, spectro-
into NIH 3T3 cells (Abe et al., 1999). Mutation of Tyr174 scopic, and computational methodologies. Sequential
to phenylalanine also potentiates DH mediated transfor- assignments were obtained from a selectively methyl-
mation (Lopez-Lago et al., 2000). In contrast, Tyr!Phe protonated (Leu, Val, and Ile [d1 only]), otherwise 2H/15N/
mutations at the other N-terminal phosphorylation sites 13C-labeled sample, using heteronuclear three-dimen-
(Tyr142 and Tyr160) (Lopez-Lago et al., 2000) and trun- sional NMR experiments designed specifically for deu-
cations of Vav at residues 127 or 168 (Abe et al., 1999), terated systems (see Experimental Procedures). Methyl
increase the oncogenic potential to a lesser degree, resonances were obtained from methyl-optimized HCC-
implicating Tyr174 as a key regulatory site. Taken to- TOCSY-NNH and CCC-TOCSY-NNH NMR experiments
gether, these data imply that the N terminus of Vav is (Gardner et al., 1996). Aromatic ring proton assignments
autoinhibitory and phosphorylation of Tyr174 relieves were obtained using 2D TOCSY and NOESY experi-
this negative regulation. ments (Wuthrich, 1986) performed on a selectively
In this study, we have determined the solution struc- methyl-protonated, otherwise deuterated sample with
ture of the autoinhibited Vav DH domain (residues 170– the additional labeling of 1H/12C/14N at the Tyr and Phe
375) and characterized its structural changes on phos- positions. The remaining side chain resonances were
phorylation at Tyr174. The conserved portion of the assigned from standard NMR experiments on a 13C/15N/
domain (residues 186–375) is architecturally similar to 1H-labeled sample. The use of deuteration in conjunction
other members of the Dbl family. The N-terminal autoin- with selective protonation of residues forming the hy-
hibitory extension forms an a helix that binds in the drophobic core allowed us to acquire a series of three-
DH domain active site through contacts to conserved and four-dimensional NOESY experiments that were
residues, blocking access to GTPases. Tyr174 forms an used in the initial protein global fold determination. In
integral part of this autoinhibitory interface, and is largely particular, the favorable relaxation properties of the se-
buried in the intramolecular complex. Phosphorylation lectively methyl- and aromatic-protonated sample al-
of Tyr174, or removal of the N-terminal peptide greatly lowed us to obtain critical NOEs between these func-
enhances the DH domain exchange activity. NMR spec- tional groups using the constant time 1H/13Cmethyl/1Haromatic
troscopic data show that phosphorylation of Tyr174 NOESY experiment (modified from Zwahlen et al., 1998).
causes the N-terminal peptide to become unstructured The high-resolution structure was subsequently ob-
and release from the DH domain. Thus, the Vav DH tained using ARIA for automated assignment of 15N- and
domain is activated through phosphorylation-mediated 13C-edited NOESY experiments (Nilges et al., 1997).
exposure of the active site.
Structure of the Vav DH Domain and Mechanism
of AutoinhibitionResults
The structure of Vav170–375 was calculated from a total
of 3432 NMR distance restraints (Table 1). In addition,To understand the mechanism of Vav DH domain activa-
tion, we examined several Vav constructs for their ability 326 chemical shift–based backbone torsion angle re-
straints obtained from the program TALOS were in-to stimulate nucleotide exchange on Rac and Cdc42.
Based on sequence comparisons with DH domains of cluded (Cornilescu et al., 1999), as were 79 side chain
torsion restraints. Figure 2 shows a backbone superpo-known structure (Aghazadeh et al., 1998; Liu et al., 1998;
Soisson et al., 1998), we expressed and purified residues sition of the 20 lowest energy structures. Residues 178–
198 are disordered due to a lack of NOEs observed181–375 of mouse Vav1 comprising the isolated DH frag-
ment. GDP release assays show that this fragment is for this region. The root mean square deviation for the
structured regions (residues 170–177 and 199–375)active toward Rac1 (Figure 1). In agreement with previ-
ous findings, no GEF activity was observed toward is 0.63 A˚ for backbone and 1.12 A˚ for all heavy atoms
(Table 1).Cdc42 under the same conditions (Figure 1). In contrast,
purified Vav170–375 containing the Tyr174 phosphoryla- The Vav DH domain is structurally similar to previously
reported DH domains (Aghazadeh et al., 1998; Liu et al.,tion site was inactive toward both Rac1 and Cdc42 (Fig-
ure 1). Activity toward Rac1 but not Cdc42 was restored 1998; Soisson et al., 1998). It is composed of 11 a helices
that form a flattened, elongated bundle, giving rise toto levels comparable to Vav181–375 through preincuba-
tion with Src tyrosine kinase under conditions leading two surfaces formed by helices D, E, F, and G and A, I,
J, and K (Figure 3A). The latter has been identified asto stoichiometric conversion of Vav to a single phos-
phorylated species (see below). Kinase assays measur- the GTPase interaction site (Liu et al., 1998) and many
of the residues required for GEF activity cluster on thising 32P incorporation showed that Vav170–375, but not
Vav181–375, was phosphorylated by Src kinase (Figure surface. These include the exposed amino acids corre-
sponding to Glu201 and Thr205 on helix A, Gln331,1, insert). Thus, in the absence of other regions of the
Autoinhibition and Activation of Vav DH Domain
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Figure 1. Rac1 and Cdc42 Nucleotide Exchange Catalyzed by Vav DH Domain Constructs
Normalized change in fluorescence (F) of (mant-GDP)-Cdc42 and Rac1 complex on addition of Vav170–375, Vav181–375, and phosphorylated
Vav170–375. The amount of Mant-GDP bound to the GTPase prior to GEF addition was defined as 100% GDP bound. Insert: phosphorylation
of Vav170–375 but not Vav181–375 by Src kinase.
Lys335 and Leu338 on helix J, Asn371 and Glu372 on 178–198) to the N terminus of the DH domain fold. This
element packs orthogonally to helices A and I acrosshelix K (Aghazadeh et al., 1998) in Vav, which are con-
served in sequence as well as the relative orientation of the center of the active site (Figure 3A). Side chains of
residues Ile173, Tyr174, and Leu177 make contacts totheir side-chains. It seems therefore that structurally the
DH domain of Vav has potential for robust exchange a hydrophobic patch created by Tyr209 and Thr212 (he-
lix A), Phe320 (H-I loop), and Leu325 and Val328 (helix I)activity. The N-terminal eight residues (170–177) con-
taining the IY(174)EDL phosphorylation motif form an of the DH domain (Figure 3B). NOEs from the N-terminal
peptide to Phe320 result in elevation of the C terminusadditional a helix attached by a flexible linker (residues
Table 1. Statistics for the Ensemble of 20 NMR Derived Structures
Restraints for structure calculationa
Total restraints 3966




Dihedral (F, C, x1, x2) 182, 182, 55, 24
Statistics for structure calculationb
rmsd from experimental restraints
Distance (A˚) 0.0015 6 0.0001
Angles (8) 0.34 6 0.01
Final Energies (kcal mol21)
Etotal 198 6 27
ENOE 38 6 15
Ecdih 4 6 3
Coordinate precisionc (residues 170–177, 199–208)
rmsd of backbone atoms 0.63 A˚ 6 0.09
(N, Ca, C9)






a The final values for the force constants employed for the various terms in the target function employed for simulated annealing are as follows:
5 kcal mol21A˚24 for the quartic van der Waals repulsion term (with van der Waals radii set to 0.78 times their value defined in the paramallhdg-
pro parameter set), 50 kcal mol21A˚22 for the experimental distance restraints, 200 kcal mol21rad22 for the experimental torsion angle restraints.
b None of the final structures have distance restraint violations greater than 0.3 A˚ or dihedral violations greater than 58.
c Defined as average root-mean-squared difference for the stated residues between the final 20 structures and the average coordinates.
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Figure 2. Stereoview of the Backbone (N, Ca, and C9) of 20 superimposed structures of Vav170–375
Residues 170–180 containing the Tyr174 phosphorylation motif are red, and residues 181–375 are black.
of helix H by z12 A˚ in our calculations compared to other Vav DH domain. We were able to phosphorylate a sam-
ple of 15N/13C-labeled Vav170–375 to a high degreeknown DH domain structures. Interestingly, side chains
(.90%), yielding a single species as monitored throughof residues corresponding to Phe320, Leu325, and
changes of 1H/15N and 1H/13C correlation spectra (FigureVal328 are exposed in DH domains of both PIX and
4A). The majority of signals in the phosphorylated andmSos (Aghazadeh et al., 1998; Soisson et al., 1998),
unphosphorylated spectra are similar, indicating nobut are buried under the autoinhibitory helix in the Vav
gross structural changes in the body of the domain.structure. Moreover, in Trio, most DH domain residues
However, changes were observed for the methyl groupsindicated in the interaction with Rac (Liu et al., 1998) map
comprising the inhibitory binding pocket (Ile173, Leu177,to regions immediately adjacent to the autoinhibitory
Leu325, and Val328) (Figure 4A). In addition, a number ofcontacts in our structure. In particular, the backbone
new resonances appeared in the 1H/15N HSQC spectrum1H/15N-HSQC resonance of Arg1369 in Trio (correspond-
(Figure 4B). These have much higher intensities com-ing to Arg332 in Vav) is affected by the titration of Rac1,
pared to the rest of the spectrum while showing poorand mutagenesis data have shown that this residue is
chemical shift dispersion in the proton dimension, indic-critical for GEF function (Liu et al., 1998). In our structure,
ative of an unstructured and mobile region. Sequentialthe guanidinium group of Arg332, which forms a con-
assignment has mapped these signals to the N-terminalserved, buried salt bridge with Glu206, appears to stabi-
14 residues of Vav170–375. Chemical shift index (CSI)lize the Tyr174 hydroxyl group, which is directed toward
analysis (Wishart and Sykes, 1994) verified that thesethe hydrophobic core of the DH domain (Figure 3B).
residues lack secondary structure in solution in theFinally, in Dbl, mutagenesis of the conserved glutamine
phosphorylated state. We therefore conclude that phos-corresponding to Gln331 in Vav, which is buried by the
phorylation of Tyr174 causes release of the N-terminalfirst turn of the autoinhibitory helix in our structure, elimi-
inhibitory arm from the body of the DH domain, exposingnates GEF activity (Zhu et al., 2000). We therefore con-
the GEF active site. Disruption of inhibitory contactsclude that Vav GEF function is inhibited through the
appears to be caused by a combination of steric clashesocclusion of residues important for GTPase binding and
between Tyr174 phosphate group and the side chainsnucleotide exchange catalysis. The tyrosine phosphory-
of Arg332 and Tyr209 (Figure 3B), and the energetic costlation motif, I/VYXXL/I, which forms the autoinhibitory
of desolvating the phosphate upon introduction into thehelix, is conserved throughout the Vav proteins, indicat-
binding pocket. Phosphorylation of threonine residuesing that this mechanism of regulation is conserved
has also been shown to destabilize helices (Szilak et al.,among this family of GEFs.
1997). It is possible that an analogous disruption of the
inhibitory helix by Tyr174 phosphorylation also contrib-
Mechanism of Activation by Tyr174 Phosphorylation utes to the weakening of contacts between Ile173 and
We next investigated the structural changes that occur Leu177 and residues Phe320 and Leu325 of the DH
body.upon phosphorylation resulting in the activation of the
Autoinhibition and Activation of Vav DH Domain
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Figure 3. Structure of the Autoinhibited Vav170–375
(A) Ribbons (Carson, 1991) depiction of a representative confomer from the final ensemble of Vav DH domain structures. Residues 170–180
encompassing the inhibitory helix are red, 181–375 are yellow, loops are green.
(B) Autoinhibited DH domain, rotated z908 about a vertical axis with respect to 3A. Left: a yellow molecular surface of the DH domain (residues
195–375) with the N-terminal autoinhibitory arm (residues 170–194) depicted as a red ribbon. Right: indicated expansion of the binding site
of the inhibitory helix on the DH domain. Residues involved in the interaction are colored green on the DH domain and red on the inhibitory
helix. Molecular surfaces of the DH domain represented as a yellow net. Figure produced with GRASP (Nicholls et al., 1991).
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Figure 4. Correlation Spectra of Phosphorylated and Unphosphorylated Vav170–375
(A) Leu/Val methyl region of 1H/13C constant-time HSQC spectrum acquired on selectively methyl labeled samples (see text) of Vav170–375
(left panel) and phosphorylated Vav170–375 (right panel). Assignment of peaks shifted upon phosphorylation are shown.
(B) Region of 1H/15N-HSQC spectrum of phosphorylated Vav. Assignment of intense peaks appearing upon phosphorylation are shown.
Resonances of Gly170 and Ser182 do not fall within the displayed region.
Discussion through phosphorylation at Tyr174 (Crespo et al., 1997;
Schuebel et al., 1998). Interestingly, this covalent modifi-
cation can be facilitated by binding of PIP3 to the PHPhosphorylation of Dbl proteins occurs in response to
stimulation of many signaling pathways, and often corre- domain, or alternatively hindered by PIP2 (Han et al.,
1998). These interactions correlate with the binding oflates with Rho protein activation in vivo. Consistent with
this, numerous kinases are known to play prominent the PH domain to a DH construct (residues 173–436),
with PIP2 enhancing, and PIP3 decreasing, the affinityroles in Rho GTPase-mediated processes, such as cell
adhesion and spreading, focal adhesion disassembly, (Das et al., 2000). This indicates that the Tyr174 phos-
phorylation site and the PH domain are thermodynami-and migration (Thomas and Brugge, 1997). In several
cases, phosphorylation has been shown to directly in- cally, and possibly structurally, coupled through phos-
pholipids. The simplest model to account for this datacrease GEF activity in vitro (Crespo et al., 1997; Fleming
et al., 1999; Kiyono et al., 2000). Therefore, tyrosine that is consistent with our autoinhibitory structure is
shown in Figure 5, where the Tyr174 phosphorylationphosphorylation–dependent activation of Rho-GEFs
may be a general mechanism for stimulation of Rho motif forms part of the interface between the PH and
DH domains. Alternate models that do not involve directGTPase responses. The best studied Rho-GEF that is
activated by tyrosine phosphorylation both in vivo and contacts between the inhibitory helix and the PH domain
are also possible, but would require more complicatedin vitro, is the Vav proto-oncogene. Src- and Syk-family
tyrosine kinases can activate the Vav DH domain means of communication between these elements. The
Autoinhibition and Activation of Vav DH Domain
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recruiting other factors involved in the signaling path-
way. Alternately, these sites could exert direct regula-
tory control over DH activity similar to Tyr174 or the PH
domain. Moreover, the multiple modes of DH domain
regulation may be the means through which additional
specificity is achieved. Thus, to stimulate Vav GEF activ-
ity, concurrent activation of PI 3-kinase as well as Src
or Syk family kinases is required. Along with the intrinsic
GEF specificity for Rac, this restricts the spatial and
temporal signaling through Vav in the cell.
The picture emerging from Vav activation in vivo is
complex and involves an intricate network of autoregula-
tory units. The structure of the autoinhibited Vav DH
domain is the first step in gaining structural insight into
Figure 5. Model of Vav DH Domain Autoinhibition by Tyr174 Src how cells elicit different responses depending on local-
Recognition Motif and PH Domain ization and collection of signals received at any given
moment.
structural and thermodynamic model leads to a signal-
Experimental Proceduresing cascade for Vav activation that is initiated by the
binding of PIP3 to the PH domain. This causes the disrup-
Molecular Biology
tion of PH domain interactions with the autoinhibited Fragments spanning residues 170–375 and 181–375 of mVav1 were
DH domain and allows access of Src-family kinases to amplified from full-length cDNA by PCR, subcloned into pET11a
Tyr174. Subsequent phosphorylation releases the Tyr174 expression vector (Novagen), and transformed into E. coli strain
BL21(DE3). Uniform 15N and 13C labeling was obtained by growingautoinhibitory helix region and results in the exposure
cells in minimal media supplemented with 15NH4Cl and/or 13C6-glu-of the DH active site.
cose as the sole nitrogen and carbon sources, respectively. FullA number of additional tyrosine phosphorylation sites
deuteration at all proton positions was obtained by growing cells
on Vav have also been identified. However, the roles in 100% D2O media supplemented with 13C62H7-glucose (Cambridge
of these in regulating GEF activity remain unclear. The Isotope Laboratories) as the sole carbon source. Selective proton-
N-terminal Lck/Syk phosphorylation sites Tyr142 and ation at methyl positions of leucine, valine, and isoleucine was ob-
tained as described (Gardner and Kay, 1997) by addition of 70 mg/Tyr160 have, like Tyr174, also been proposed to serve
liter of 13C,15N,2-2H (50%),3-2H valine (Cambridge Isotope Labora-an autoinhibitory function, based on observations that
tories) and z40 mg/liter 13C,3-2H2 a-ketobutyrate to fully deuteratedtruncations at positions 127, 168, and 186 increasingly
media 30 min before induction. Similarly, addition of 50 mg/liter
potentiate Vav transformation activity (Abe et al., 1999). unlabeled protonated tyrosine and phenylalanine lead to the proton-
Interestingly, all three sites contain the sequence motif ation of the side chains of these aromatics. Cells were grown at
`YXX` (where ` 5 Ile, Leu, or Val, and X 5 hydrophilic, 378C to an optical density of 0.8 at 600 nm. Protein expression was
induced with 1 mM isopropyl-D-thiogalactoside for 12 hr at 258Coften acidic), observed in the case of Tyr174 to form
(H2O growths) or 6 hr at 378C (100% deuterated media). Proteinan amphipathic helix lying in the GEF active site. This
was purified from bacterial lysate by anion exchange (Pharmaciasequence is also known, in phosphorylated form, to be
DEAE-CL6B) and gel filtration (Pharmacia Superdex-75) chromato-
a consensus binding motif for Src-family kinase SH2 graphies. NMR samples contained z1.4 mM protein in 20 mM phos-
domains (Songyang et al., 1993). The intervening se- phate buffer (pH 7), 50 mM NaCl, 2 mM DTT, and 0.1% NaN3. Phos-
quences between each of the sites and the DH domain phorylation reactions were performed by coincubating purified Vav
proteins and Src tyrosine kinase in a molar ratio of 50:1 in theare extremely hydrophilic, and unlikely to form discrete
presence of excess ATP for 30 min at 308C in 20 mM HEPES (pHstructures. Thus, it is possible that the `YXX` motifs
7), 50 mM NaCl, and 2 mM MgCl2. Phosphorylation reactions wereat Tyr142 and Tyr160 can also bind, likely with lower
monitored for 32P incorporation by SDS-PAGE and autoradiography.
affinity than the Tyr174 motif, in inhibitory fashion to the Purified Src was a gift from Yong-Chao Ma in the Huang laboratory.
GEF active site. This semi-equivalence suggests that in
the full-length protein, phosphorylation of all three sites Nucleotide Exchange Assays
may be necessary to obtain maximal GEF activity, and Rac or Cdc42 were preloaded with Mant-GDP (Molecular Probes)
provides a mechanism to achieve graded activity de- by incubation with the fluorescent labeled nucleotide in the presence
of excess EDTA as described (Nomanbhoy et al., 1996). The reactionpending on the level of kinase signaling. Repeated use
was quenched by adding excess MgCl2, and unbound nucleotideof the `YXX` motif may also facilitate efficient relief
extracted using buffer exchange columns (Pharmacia). Ten nano-of autoinhibition in vivo. Initial phosphorylation at one
grams of GTPase loaded with Mant-GDP was incubated in a buffer
exposed site could position the kinase, through SH2 containing 20 mM HEPES (pH 7), 50 mM NaCl, and 2 mM MgCl2 at
domain interactions, for enhanced capture of Tyr174 as 258C. To initiate Vav-induced Mant-GDP/GDP exchange, 500 ng
it stochastically dissociates from the DH domain under exchange factor was added together with 2.1mM GDP. The time
course of fluorescence was monitored using a Fluoromax-II spec-thermodynamic control. Sequential processes involving
trofluorometer with lexcitation at 350 nm and lemission at 440 nm.initial contact with an accessible site, followed by bind-
ing or modification of a less accessible regulatory site
NMR Spectroscopymay be a common feature of kinetic pathways leading
NMR experiments were carried out at 258C on a Varian Innova 600to relief of autoinhibition.
MHz spectrometer equipped with 4 channels and pulsed field gradi-
Vav can also be phosphorylated at C-terminal sites ents. Data were processed using NMRpipe (Delaglio et al., 1995) and
in vivo. Like the N-terminal sites, these may be involved analyzed with NMRview software packages (Johnson and Blevins,
1994). Backbone 1HN, 15N, 13Ca, 13Cb, and 13CO assignments werein intracellular targeting of the parent molecule or in
Cell
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al. (1998). Oligophrenin-1 encodes a rhoGAP protein involved inrestraints for structure calculation: 3D 15N-edited NOESY (40 ms, 70
X-linked mental retardation. Nature 392, 923–926.ms mixing time; 15N-labeled sample); 3D 13C-edited NOESY (75 ms);
Boguski, M., and McCormick, F. (1993). Proteins regulating Ras and3D constant time 13C-edited NOESY (175 ms), 2D 1H NOESY (150
its relatives. Nature 366, 643–654.ms), 4D 13C/13C edited NOESY (175 ms), 4D 15N/15N-edited NOESY
(175 ms), and 4D 13C/15N edited NOESY (175 ms). Bourne, H.R., Sanders, D.A., and McCormick, F. (1991). The GTPase
A total of 55 x1 (62082408) and 24 x2 dihedral restraints (6408, superfamily: conserved structure and molecular mechanism. Nature
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and sequential NOEs in the 15N- and 13C-edited NOESY spectra. Brunati, A.M., Donella-Deana, A., Ruzzene, M., Marin, O., and Pinna,
Stereospecific assignments of valine and leucine methyl groups L.A. (1995). Site specificity of p72syk protein tyrosine kinase: effi-
were obtained from a CT-1H/13C HSQC spectrum of a 10% 13C- cient phosphorylation of motifs recognized by Src homology 2 do-
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